FindTrial
Sign In

Sex-specific Differences in the Outcome of Critically ill COVID-19 Patients

Sex-specific Differences in the Outcome of Critically ill COVID-19 Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031724
Enrollment
2000
Registered
2023-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical COVID-19

Interventions

Group 1: Patients with male sex: The study will investigate the manifestations of baseline characteristics (including demographic data, pre-existing conditions, pre-medication, disease severity upon a

Sponsors

Charité Universitätsmedizin – Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Berlin, Germany
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: admission to an intensive care unit primary diagnosis of COVID-19 during ICU treatment

Exclusion criteria

Exclusion criteria: Age < 18 years Incidental COVID-19

Design outcomes

Primary

MeasureTime frame
In-hospital Mortality—

Secondary

MeasureTime frame
ICU-mortality—

Countries

Germany

Contacts

Public ContactJan-Hendrik Bernhard Hardenberg

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Nephrology and Medical Intensive Care, Augustenburger Platz 1, 13353 Berlin, Germany

Jan.hardenberg@charite.de+49030450614389

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026